Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2021-05-06 | New | $5,445,363 | Unknown | Equity Only | SEC link | |
| 2017-11-21 | New | $3,000,000 | $3,000,000 | Equity Only | 06b | SEC link |
| 2017-07-10 | Amended | $12,300,000 | $8,300,000 | Debt Only | 06b | SEC link |
| 2016-07-27 | New | $4,000,000 | $4,000,000 | Debt Only | 06b | SEC link |
| 2016-07-27 | Amended | $50,402,467 | $6,000,000 | Equity Only | 06b | SEC link |
| 2016-02-22 | Amended | $44,402,467 | $6,394,143 | Equity Only | 06b | SEC link |
| 2015-03-18 | Amended | $38,008,324 | $11,372,000 | Equity Only | 06b | SEC link |
| 2014-03-12 | Amended | $26,636,324 | $8,704,970 | Equity Only | 06b | SEC link |
| 2013-11-08 | New | $17,931,354 | $17,931,354 | Equity Only | 06b | SEC link |
| 2013-06-04 | Amended | $4,307,884 | $2,498,329 | Debt Only | 06 | SEC link |
| 2013-04-29 | New | $1,809,555 | $1,809,555 | Debt Only | 06 | SEC link |
| 2012-06-21 | New | $5,000,000 | $5,000,000 | Debt Only | 06 | SEC link |
| 2011-12-14 | New | $18,784,666 | $18,784,666 | Equity Only | 06 | SEC link |
| 2011-07-15 | Amended | $9,694,400 | $5,201,700 | Debt Only | 06 | SEC link |
| 2010-10-27 | New | $4,492,700 | $4,492,700 | Debt Only | 06 | SEC link |
| 2010-03-16 | Amended | $4,151,043 | $0 | Equity Only | 06 | SEC link |
| 2009-11-27 | New | $6,000,000 | $4,151,043 | Equity Only | 06 | SEC link |
| 2009-05-28 | Amended | $6,270,000 | Unknown | Equity Only | SEC link | |
| 2009-02-12 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2008-04-25 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2007-04-11 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| Dan Bowen | Director |
| Steve Burpee | Director |
| Janet Burpee | Executive |
| Michael Caponetto | Director |
| Robert Croce | Director, Executive |
| Richard Dakers | Director |
| Jack Darby | Director, Executive |
| Fernando Di Caprio | Director, Executive |
| David R. Fischell | Director |
| Tim A. Fischell | Executive |
| Robert E. Fischell | Director, Executive |
| Robert Flanagan | Director |
| Michael Johnson | Executive |
| Mark A. Kielek | Executive |
| Timothy Lash | Director |
| Mark Pomeranz | Executive |
| Joseph Smith | Director |
| Mina Sooch | Director |
| Richard T. Spencer | Executive |
| Somu Subramaniam | Director |
| Phillip D. Torrence | Executive |
| Nicholas Valeriani | Director |